1 follower
Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way.
Industries
Headquarters
Stage
Employees
Links
Stephen S. Yoder
0 members
Relmada Therapeutics
Aldeyra Therapeutics
Onconova Therapeutics
Agile Therapeutics
3 followers
VistaGen Therapeutics
Discover companies